Elobixibat
- Generic Name
- Elobixibat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C36H45N3O7S2
- CAS Number
- 439087-18-0
- Unique Ingredient Identifier
- 865UEK4EJC
- Background
Elobixibat has been used in trials studying the treatment and basic science of Dyslipidemia, Constipation, Chronic Constipation, Functional Constipation, and Chronic Idiopathic Constipation.
- Associated Conditions
- -
- Associated Therapies
- -
A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2021-09-27
- Lead Sponsor
- Albireo
- Target Recruit Count
- 47
- Registration Number
- NCT04006145
- Locations
- ๐บ๐ธ
Integrity Clinical Research, LLC, Doral, Florida, United States
๐บ๐ธMercy Medical Center, Baltimore, Maryland, United States
๐บ๐ธAmerican Research Corporation at the Texas Liver Institute, San Antonio, Texas, United States
Elobixibat Colonic Motor Function Study
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Ferring Pharmaceuticals
- Registration Number
- NCT02392546
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2024. All Rights Reserved by MedPath